Legend Biotech (LEGN) Profit After Tax (2019 - 2025)

Legend Biotech (LEGN) has reported Profit After Tax for 7 consecutive years, with $30.9 million the latest figure, recorded in Q4 2025.

• Profit After Tax for Q4 2025 came in at $30.9 million, up 17.05% year-over-year; the trailing twelve-month figure through Dec 2025 was $98.6 million (down 10.45% YoY), and the FY2025 annual result was -$296.8 million, down 67.68% from the prior year.
• Profit After Tax was $30.9 million for Q4 2025 at Legend Biotech, down from $39.7 million in the prior quarter.
• Over five years, Profit After Tax peaked at $535.4 million in Q3 2022 and troughed at -$410.8 million in Q4 2021.
• Average Profit After Tax over 5 years is -$17.6 million, with a median of -$16.1 million recorded in 2022.
• Year-over-year, Profit After Tax sank 32288.91% in 2022 and surged 18329.78% in 2024.
• Over 5 years, Profit After Tax stood at -$410.8 million in 2021, then soared by 67.0% to -$135.6 million in 2022, then jumped by 99.89% to -$144818.0 in 2023, then soared by 18329.78% to $26.4 million in 2024, then advanced by 17.05% to $30.9 million in 2025.
• Per Business Quant data, the three most recent Profit After Tax figures were $30.9 million in Q4 2025, $39.7 million in Q3 2025, and $125.4 million in Q2 2025.